Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation

Toshiyuki Miyata1, Rina Kimura, Yoshihiro Kokubo

  • 1Research Institute, National Cardiovascular Center, Suita, Osaka, Japan. miyata@ri.ncvc.go.jp

Insights

Ethnic variations in disease mutations necessitate population-specific research. In Japanese individuals, protein S mutation K196E is a significant genetic risk factor for deep vein thrombosis, requiring targeted screening.

Area of Science:

  • Genetics and Molecular Biology
  • Thrombophilia and Hemostasis Research
  • Population Health Studies

Background:

  • Disease-associated mutations exhibit varying frequencies across ethnic groups, underscoring the need for ethnicity-specific investigations.
  • Previous studies have indicated ethnic disparities in the genetic underpinnings of thrombophilia.

Purpose of the Study:

  • To investigate the prevalence of deficiencies in plasma proteins C, S, antithrombin, and plasminogen within the Japanese population.
  • To identify genetic factors contributing to deep vein thrombosis (DVT) in this demographic.
  • To assess the clinical significance of the protein S K196E mutation in the Japanese population.

Main Methods:

  • Conducted a large-scale analysis of plasma activities for proteins C, S, antithrombin, and plasminogen in the general Japanese population.
  • Evaluated the genetic contribution of specific mutations, including protein S K196E, to the risk of deep vein thrombosis.
  • Estimated allele frequencies and calculated the potential number of affected individuals.

Main Results:

  • Prevalence of deficiencies: Protein C (0.13%), antithrombin (0.15%), protein S (1.12%), and plasminogen (4.29%).
  • Identified protein S mutation K196E as a significant genetic risk factor for DVT in the Japanese population, with an estimated allele frequency of 0.009.
  • Approximately 1 in 12,000 Japanese individuals may be homozygous for the K196E allele, potentially affecting up to 10,000 people.

Conclusions:

  • A substantial portion of the Japanese population carries the protein S E allele, increasing their risk for deep vein thrombosis.
  • The high frequency and strong association of the protein S K196E mutation with DVT suggest the value of large-scale screening.
  • Individuals identified with this allele should be advised to mitigate environmental risk factors associated with DVT.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...